资讯

China.org.cn4 小时
1st LD Writethru: DPRK to build 3rd Choe Hyon-class destroyer
In a mobilization gathering held on Monday, the Nampho Shipyard pledged to build Choe Hyon-class Destroyer No. 3 by Oct. 10, 2026, a date marking the founding of the Workers' Party of Korea, the ...
China.org.cn8 小时
DPRK to build 3rd Choe Hyon-class destroyer
In a mobilization gathering held on Monday, the Nampho Shipyard pledged to build its third Choe Hyon-class destroyer by Oct. 10, 2026, a date marking the founding of the Workers' Party of Korea, the ...
口服多肽向FDA递交上市申请 药明康德共同强生等参与
据 药明康德 （603259.SH） 官微7月22日消息，药明康德共同强生（Johnson & Johnson）与Protagonist Therapeutics今日宣布，已向美国FDA提交新药申请（NDA），寻求批准其在研、每日一次口服多肽疗法icotrokinra（JNJ-2113）上市， 用于治疗12岁及以上中度至重度斑块状银屑病（PsO）成人与儿科患者 ...